Gene therapy for antiangiogenesis (interference with EGFR expression, using an antisense-based gene therapy approach, may be an effective means of treating EGFR-overexpressing tumors, including SCCHN). - Kleinman,H.K.; Liau,G.; He,Y.; Zeng,Q.; Drenning,S.D.; Melhem,M.F.; Tweardy,D.J.; Huang,L.; Grandis,J.R. (J Natl Cancer Inst, 2001)